ClinConnect ClinConnect Logo
Search / Trial NCT06762496

A New Tool to Promote Patient's Engagement in Their Healthcare Process

Launched by EUROPEAN INSTITUTE OF ONCOLOGY · Dec 31, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Early Breast Cancer Patient Decision Engagement

ClinConnect Summary

This clinical trial is focused on helping women who have been diagnosed with early-stage breast cancer make important decisions about their treatment options. The goal is to create a new tool that can guide patients in understanding their choices and selecting the best treatment for their specific situation. This study will test how effective this tool is in assisting patients during their decision-making process.

To be eligible for the trial, participants must be at least 18 years old and have been diagnosed with early-stage breast cancer that can be surgically removed. They should also be preparing to start treatment for their cancer and be able to provide consent to participate. Women with certain psychological or cognitive issues, advanced cancer, or other serious health conditions may not be able to join. Although the trial is not yet recruiting participants, those who take part can expect to receive support in understanding their treatment options, which can help them feel more engaged and confident in their healthcare journey.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • be 18 or older;
  • have received/receive diagnosis of resectable breast cancer in the early stage;
  • women treated or who will undergo oncological treatment for early breast cancer;
  • demonstrate the absence of psychopathological features.
  • be willing and able to provide written informed consent/assent for the trial
  • Exclusion Criteria:
  • breast cancer patients who showed physical or psychological issues, as well as cognitive impairments that prohibited their participation in this type of study;
  • neurological or psychiatric disorders that may compromise the patients' ability to take part in the study.
  • Distant metastases from breast cancer or locally advanced/unresectable disease
  • Known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial

About European Institute Of Oncology

The European Institute of Oncology (IEO) is a leading research and treatment center based in Milan, Italy, dedicated to advancing cancer care through innovative clinical research and personalized medicine. Renowned for its commitment to multidisciplinary approaches, IEO integrates cutting-edge research with clinical practice to improve patient outcomes. The institute actively sponsors and conducts clinical trials across various cancer types, fostering collaboration between oncologists, researchers, and industry partners. With a focus on translating scientific discoveries into effective therapies, IEO plays a pivotal role in the global fight against cancer, contributing to the development of new treatment protocols and enhancing the understanding of oncological diseases.

Locations

Milan, , Italy

Patients applied

0 patients applied

Trial Officials

Gabriella Pravettoni

Principal Investigator

European Institute of Oncology

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported